Bausch Health Companies (BHC) vs Ironwood Pharmaceuticals (IRWD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Ironwood Pharmaceuticals (IRWD) has outperformed Bausch Health Companies (BHC) over the past year, gaining 144.9% versus a loss of 4.7%. Over five years, IRWD leads with a -71.7% price change compared with -78.8% for BHC. Bausch Health Companies is the larger company by market cap ($2.26 billion vs $639.5 million), about 3.5 times the size.
On valuation, Bausch Health Companies trades at a lower forward P/E (1.4x vs 2.6x for Ironwood Pharmaceuticals).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BHC | IRWD |
|---|---|---|
| Share price | $6.04 | $3.87 |
| Market cap | $2.26B | $639.48M |
| 1-day change | -1.79% | +3.20% |
| YTD return | -13.09% | +14.84% |
| 1-year return | -4.73% | +144.94% |
| 5-year return | -78.80% | -71.67% |
| P/E ratio (TTM) | — | 5.03 |
| Forward P/E | 1.44 | 2.58 |
| EPS (TTM) | $-2.95 | $0.77 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $10.27B | — |
| Revenue growth (YoY) | +6.66% | — |
| Net income (latest FY) | $157.00M | — |
| Operating margin | 17.66% | — |
| Net margin | 1.53% | — |
| 52-week high | $8.00 | $5.78 |
| 52-week low | $4.33 | $1.41 |
| Distance from 52-week high | -24.50% | -33.04% |
| Analyst consensus | hold | none |
| Avg. price target upside | +24.17% | +57.62% |
| Average volume | 3.24M | 2.02M |
| Shares outstanding | 373.99M | 165.24M |
| Employees | 20,300 | 100 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Bausch Health Companies is about 3.5 times larger than Ironwood Pharmaceuticals by market value ($2.26B vs $639.48M).
- IRWD has outperformed BHC by 149.7 percentage points over the past year.
About Bausch Health Companies
BHC stock →Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company.
Health Care · Biotechnology: Pharmaceutical Preparations · 20,300 employees
About Ironwood Pharmaceuticals
IRWD stock →Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally. It sells linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation, as well as for pediatric patients suffering from functional constipation under the LINZESS and CONSTELLA names.
Health Care · Biotechnology: Pharmaceutical Preparations · 100 employees
BHC vs IRWD FAQ
Which is bigger, Bausch Health Companies or Ironwood Pharmaceuticals?
Bausch Health Companies (BHC) is larger, with a market capitalization of $2.26B compared with $639.48M for Ironwood Pharmaceuticals (IRWD).
Which stock has performed better over the past year, BHC or IRWD?
IRWD returned +144.94% over the past 12 months, compared with -4.73% for BHC (price return, excluding dividends). Past performance does not predict future results.
Are Bausch Health Companies and Ironwood Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.